Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Squamous Cell Carcinoma
and you are
between 20 and 79
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

A phase II study to evaluate the efficacy and safety of Docetaxel-PM in recurrent or metastatic head and neck squamous cell carcinoma

Provided treatments

  • Drug: Docetaxel-PM
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02639858. The sponsor of the trial is Samyang Biopharmaceuticals Corporation and it is looking for 31 volunteers for the current phase.
Official trial title:
A Phase II Study to Evaluate the Efficacy and Safety of Docetaxel-PM in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma